BioWorld

Aug. 27, 2002

Alkermes Trims Staff By 23% After Risperdal Consta Delay

The fallout continues at Alkermes Inc., which following a series of recent setbacks reported a 23 percent reduction in its work force. (BioWorld Today) Read More

Bush Insider McClellan Appears To Head FDA Commissioner List

Herpes Infects Mouse Virus To Take On Complement Killers In Acute, Chronic, Latent Infection

Uncertainties Around Finances, Elan Lead Incara To Stop Trial

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Jan 26, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 27, 2026.

DNA mutations or genetic disorder concept art

Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease

BioWorld Science

Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...

Brain-derived tau in blood predicts stroke severity and outcome

BioWorld Science

Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...

Muted and missing M&As: JPM deals absent in 2026

BioWorld

For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...